Stay updated with breaking news from Path Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bangor Savings Bank raised its position in UiPath Inc. (NYSE:PATH – Free Report) by 109,876.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,487 shares of the healthcare company’s stock after buying an additional 60,432 shares during the quarter. Bangor […]
Invictus Private Wealth LLC boosted its holdings in UiPath Inc. (NYSE:PATH – Free Report) by 35.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 219,386 shares of the healthcare company’s stock after purchasing an additional 57,786 shares during the quarter. UiPath makes up 0.5% of Invictus Private Wealth LLC’s portfolio, making the stock […]
UiPath (NYSE:PATH – Free Report) had its price objective upped by DA Davidson from $16.00 to $17.00 in a research report sent to investors on Thursday, Marketbeat.com reports. The brokerage currently has a neutral rating on the healthcare company’s stock. Several other equities analysts have also recently weighed in on PATH. Bank of America raised […]
UiPath (NYSE:PATH – Free Report) had its price target boosted by Royal Bank of Canada from $18.00 to $19.00 in a research report released on Thursday, MarketBeat reports. The firm currently has a sector perform rating on the healthcare company’s stock. Several other brokerages have also issued reports on PATH. Wells Fargo & Company lowered […]
Needham & Company LLC reissued their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $20.00 price objective on the healthcare company’s stock. A number of other brokerages have also recently commented on PATH. Barclays boosted their price objective on UiPath […]